Angela Lee Zarling

Title: Angela Lee Zarling: Innovator in Immunotherapy

Introduction

Angela Lee Zarling is a prominent inventor based in Charlottesville, VA (US). She has made significant contributions to the field of immunotherapy, particularly through her innovative work on T cell receptors. With a total of 3 patents, her research has the potential to impact cancer treatment and diagnostics.

Latest Patents

One of her latest patents is titled "Isolated T cell receptors and methods of use therefor." This patent provides isolated T cell receptors (TCRs), TCR-like molecules, and portions that bind to phosphopeptide-HLA-A2 complexes. The isolated TCRs can be soluble and are accompanied by isolated nucleic acids encoding these TCRs, host cells containing them, and pharmaceutical compositions that include these components. Another significant patent is "Target peptides for immunotherapy and diagnostics." This patent presents a set of target peptides recognized by various HLA types on the surface of disease cells. These peptides are designed to stimulate immune responses against proliferative diseases, such as cancer, and serve multiple roles in immunotherapeutics and diagnostics.

Career Highlights

Angela has worked at esteemed institutions, including the University of Virginia and the University of Birmingham. Her research has focused on advancing the understanding and application of T cell receptors in therapeutic settings.

Collaborations

Throughout her career, Angela has collaborated with notable colleagues, including Victor H Engelhard and Kara L Cummings. These partnerships have contributed to her innovative research and the development of her patents.

Conclusion

Angela Lee Zarling is a trailblazer in the field of immunotherapy, with her patents paving the way for advancements in cancer treatment and diagnostics. Her work exemplifies the impact of innovative research on healthcare.